Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley May 25, 2026 Life Science
Strong Performance in Healthcare Sector Driven by Multiple Positive Factors May 22, 2026 Life Science
Pfizer’s 50% Stock Crash: A Hidden Contrarian Buy Amid Booming Healthcare Sector May 22, 2026 Life Science
Three Recession-Resistant Stocks Worth Investors’ Attention May 22, 2026 Consumer Goods, Life Science
The Market Underestimates Bristol-Myers Squibb’s New Product Growth Potential May 21, 2026 Life Science
Can Viking Therapeutics Replicate Eli Lilly’s Success in the Weight-Loss Drug Market? May 21, 2026 Life Science
CVS Health Stock Rallies 24% in a Month as Business Turnback Fuels Rebound May 20, 2026 Financial Service, Life Science
Dyne Therapeutics Stock Rises 40% in a Year, but Saturn V Fund Reduces Holdings May 20, 2026 Life Science
These Two Healthcare Giants Set for Fresh Dividend Hikes, Ideal Time to Invest May 19, 2026 Life Science
Can Novo Nordisk Stage a Turnaround on Wegovy Data and Robust Drug Pipeline? May 13, 2026 Life Science
Pfizer’s 6.7% Dividend: Can It Survive Plunging Profits and Cash Flow Crunch? May 12, 2026 Life Science
Hantavirus Fears Fuel Moderna Rally: Is This a Real Catalyst or Just Sentiment? May 11, 2026 Life Science
Eli Lilly Stock Hits Bottleneck After 400% Surge in Five Years, Novo Nordisk Poised for a Comeback with 4% Dividend Yield May 8, 2026 Life Science
Two High-Yield Healthcare Stocks: Top Picks for Retirement Portfolios May 8, 2026 Life Science, Real Estate
